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The influenza virus hemagglutinin (HA) contains three highly conserved cysteine residues at positions 551, 559, and 562
close to the carboxyl-terminus of the HA2 subunit which serve as palmitylation sites. Wild-type HA of influenza virus
A/FPV/Rostock/34 (H7N1) and HA permutated by exchange of the acylated cysteine to serine residues were expressed in
CV-1 cells by a SV40 vector system. Since density of immunostained HA on the cell surface measured by flow cytometric
analysis did not differ between wild-type and acylation mutants, it was possible to compare acylation mutants and wild-type
HA for their capacity to induce membrane fusion at low pH. The following observations were made: (1) lateral diffusion of
a lipid-like fluorophore (R-18) from the erythrocyte membrane to the plasma membrane of cells expressing HA on the surface
occurred equally well with mutants and wild type. (2) Diffusion of a low-molecular-weight fluorescent water-soluble probe
(calcein) from erythrocytes into the cytoplasm of HA-expressing cells was not altered either. (3) However, depending on the
position and the number of the deleted acylation sites, the mutants showed a reduced ability to induce syncytia. The data
indicate that deacylation of the cytoplasmic tail has no measurable effect on the capacity of HA to induce membrane fusion
and pore formation but that it suppresses syncytia formation. © 1998 Academic Press
INTRODUCTION
The influenza A virus envelope consists of a host-
derived lipid bilayer with three virus coded integral pro-
teins, hemagglutinin (HA) responsible for receptor bind-
ing and membrane fusion; neuraminidase (NA), which is
the receptor destroying enzyme; and M2, which has the
function of an ion channel (reviewed by Lamb and Krug,
1996). Maturation of HA involves posttranslational cleav-
age of the precursor HA0 into the disulfide-linked sub-
units HA1 and HA2 (reviewed by Klenk and Garten, 1994).
HA1 forms the globular domain of the HA spike and
carries the receptor-binding site. The HA2 subunit has
the hydrophobic fusion peptide at its N-terminal end
(Daniels et al., 1985; Gething et al., 1986a; Steinhauer et
al., 1995). The central portion of HA2 is rich in a-helices
and forms the stem of the HA ectodomain. The trans-
membrane domain and the cytoplasmic domain are lo-
cated at the C-terminal end of HA2 (Wiley and Skehel,
1987). Membrane fusion exerted by HA requires, in ad-
dition to proteolytic cleavage, a shift to acidic pH (Huang
et al., 1981) that triggers conformational changes of the
molecule. Based on the X-ray crystal structure of a frag-
ment of the HA ectodomain from X31 (Bullough et al.,
1994) and on studies of a corresponding synthetic pep-
tide (Carr and Kim, 1993), it has been concluded that the
conformational changes mainly cause an extension of
the trimeric a-helices of the stem with a transposition of
the fusion peptide from the lower part to the tip of the
spike. Penetration of the exposed fusion peptide into the
target membrane is then believed to initiate fusion (re-
viewed by White, 1994). Thus it is clear that the ectodo-
main plays an important role in HA functions.
In contrast, the involvement of the cytoplasmic domain
in HA functions is only poorly understood. The cytoplas-
mic domain consists of 10–11 amino acids of which 5
residues are conserved in all subtypes of influenza A
viruses (Nobusawa et al., 1991). Evidence has been ob-
tained from reversed genetics studies that the cytoplas-
mic tail is of some advantage but not an absolute re-
quirement for virus formation (Jin et al., 1994, 1997). HA2
has long been known to be acylated (Schmidt, 1982;
Lambrecht and Schmidt, 1986), and site-specific mu-
tagenesis revealed that three highly conserved cysteine
residues located at the transition of the transmembrane
domain to the cytoplasmic domain and within the cyto-
plasmic domain are palmitylated through a thioester
bond (Naeve and Williams, 1990; Steinhauer et al., 1991;
Veit et al., 1991; Naim et al., 1992; Simpson and Lamb,
1992; Philipp et al., 1995). All of these studies showed
that acylation did not have a significant effect on biosyn-
thesis nor on intracellular transport or on receptor-bind-
ing capacity. However, the observations made on fusion
were not consistent. In one study it was reported that
loss of fatty acids interfered with fusion (Naeve and
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Williams, 1990), whereas no such effect was observed in
the other studies. Recently it was shown that fatty acids
at the cytoplasmic tail of HA (H3 subtype) are essential
for pore flickering, an early event in the fusion process
(Melikyan et al., 1997). Furthermore, it has been reported
in studies employing reversed genetics that elimination
of acylation sites prevented formation of infectious virus
of subtype H1 (Zurcher et al., 1994), whereas no effect
was observed on virus formation of a H3 strain (Jin et al.,
1996, 1997).
Several distinct stages in the fusion process have
been discriminated, including membrane fusion, pore
formation, and dilation of the fusion pore (reviewed by
White, 1994; Blumenthal et al., 1996; Kanaseki et al.,
1997). In the present study, acylation mutants of FPV HA
have been analyzed to determine the effect of the fatty
acids on the individual steps of the fusion process. We
will show that deacylation does not affect membrane
fusion and formation of fusion pores but that it sup-
presses syncytia formation.
RESULTS
Expression of HA wt and HA mutants
HA wt and mutated HA of FPV were expressed by the
SV40 vector system. Such vectorially expressed HA has
reduced fusion activity resulting from denaturation of HA
in the acidic milieu of the exocytotic pathway. Since
surface expression of HA with optimal biological activi-
ties is required for comparative fusion studies, denatur-
ation of HA was prevented by addition of the acidotropic
agent ammonium chloride into the media of all experi-
ments (Ohuchi et al., 1994). The acylation mutants with
one, two, or all three cysteine residues substituted by
serine residues at the amino acid positions 551, 559, and
562 (Veit et al., 1991), are shown in Fig. 1. Mutant R339G,
which is activated only after addition of trypsin to the
medium, was used as a negative control for fusion (Vey
et al., 1992). The expression levels in CV-1 cells of HA wt
and mutated HA were examined by immunoprecipitation
followed by SDS–PAGE and fluorography (Fig. 2A). The
degree of acylation of the mutants was estimated by
comparing the incorporation of [35S]methionine and
[3H]palmitic acid label. To prevent removal of fatty acids
by b-mercaptoethanol, gels were run under nonreducing
conditions. The data show that there is a decrease in
[3H]palmitic acid incorporation in the order wt, mutants
lacking one acylation site, and mutants lacking two ac-
ylation sites, and that mutant C551/559/562S is not la-
beled with [3H]palmitic acid. Thus it is clear that the
amount of fatty acids attached corresponds to the num-
ber of acylation sites.
It was previously shown that the surface density of HA
is an important factor in fusion activity (Ellens et al., 1990;
Clague et al., 1991; Danieli et al., 1996). Therefore, CV-1
cells were infected with SV40 recombinant virus at mul-
tiplicities of infection that allowed equal expression rates
of mutant and wt HA. HA expression at the cell surface
was controlled by flow-cytometric analysis (FACS). The
percentage of cells expressing HA as well as the mean
fluorescence intensities of counted cells which repre-
sent the surface density of HA did not vary significantly
(Table 1). This includes also the expression levels of the
noncleavage mutant R3339G. These data indicate that wt
and all mutants are expressed with similar frequencies
and with similar densities on the cell surfaces.
Membrane fusion
Mixing of lipids between the membranes is one of
the first steps of the HA-mediated fusion event that is
experimentally detectable (Kemble et al., 1994). We
have therefore labeled erythrocytes with octadecylrho-
FIG. 2. Expression and acylation rates of wt and mutant HA. HA was
immunoprecipitated from lysates of SV40-HA infected CV-1 cells that
were metabolically labeled for 4 h with [35S]methionine or [3H]palmitic
acid and subjected to SDS–PAGE followed by fluorography.
FIG. 1. Altered fatty acid attachment sites in the FPV hemagglutinin.
The C-terminal amino acid sequence comprising the transmembrane
domain and the cytoplasmic domain of HA of influenza virus A/FPV/
Rostock/34 (H7N1) is shown. Mutants are designated according to the
exchanged cysteine residues. Previous designations (Veit et al., 1991)
are indicated in brackets.
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damine (R18) and have examined the exchange of the
lipid soluble fluorescence dye with HA expressing
CV-1 cells. HA-expressing CV-1 cells were identified
by hemadsorption under the phase contrast micro-
scope (Fig. 3, top). When fusion was induced by ex-
posure of the cultures to low pH, the fluorescent dye
diffused from the erythrocytes to the monolayers. It
was interesting to see that the label spread from
hemadsorbing CV-1 cells to adjacent ones without
bound erythrocytes (Fig. 3, bottom). This process
reached its maximum within a few minutes. No in-
crease of surface staining of the hemadsorbing cells
or of neighbouring CV-1 cells was observed after 5 min
or longer periods of incubation. All the hemadsorbing
cells showed R18 surface fluorescence, and the tran-
sition rate of R18 to neighbouring cells was similar for
HA wt and all acylation mutants (Fig. 3). After fusion,
erythrocytes showed diminished fluorescence intensi-
ties as compared to bound but nonfused erythrocytes
that were visible as single, small spots of high inten-
sity. The HA wt and the acylation mutants did not show
fusion when they were not subjected to low pH after
hemadsorption (data not shown). In another control
experiment, in which the HA mutant R339G expressing
uncleaved HA in CV-1 cells was analyzed, no fusion
was observed either. These results indicate that mem-
brane fusion does not depend on number and local-
ization of the acylation attachment sites (Fig. 3).
We have also compared the fusion kinetics of HA wt
and mutants using the R18 fluorescence dequenching
assay. Optimal dequenching was obtained when the
number of R18-containing erythrocytes was reduced by
mixing with unlabelled erythrocytes at a ratio of 1:4. The
time course of fluorescence dequenching (FDQ) did not
differ between HA wt and mutant C551/559/562S (Fig. 4)
or the other acylation mutants. No differences were ob-
served, either, when the experiments were performed at
lower temperatures (30 and 25°C). In control experi-
ments done without acidification, dequenching did not
occur (data not shown). These data support also the
notion that HA-induced membrane fusion does not de-
pend on acylation.
Formation of aqueous fusion pores
To find out whether the acylation mutants might be
altered in their ability to develop an aqueous pore, the
next stage in the fusion process, we examined the trans-
fer of the small soluble fluorescence dye calcein (Fig. 5).
Calcein-labeled erythrocytes were adsorbed to CV-1
cells expressing HA as shown in Fig. 5, top. After low pH
treatment of the cell cultures and incubation at 37°C for
20 min, calcein entering the cytoplasm of the CV-1 cells
was monitored under a fluorescence microscope. No
differences in intracellular fluorescence patterns were
found in CV-1 cell cultures expressing wt and acylation
mutants (Fig. 5, bottom). The erythrocytes appeared to be
swollen after induction of fusion but could still be distin-
guished from the CV-1 cells to which they were attached,
indicating that fusion had not proceeded beyond pore
opening. Interestingly, CV-1 cells in contact with hemad-
sorbing cells also showed fluorescence in their cyto-
plasm, indicating that aqueous fusion pores are formed
not only between CV-1 cells and erythrocytes but also
between neighbouring CV-1 cells. No difference between
wt and mutant HA was observed for calcein redistribu-
tion between CV-1 cells. CV-1 cells expressing un-
cleaved HA of the mutant R339G at their surface showed
hemadsorption but were not stained with calcein, con-
firming that uncleaved HA does not form fusion pores
(Fig. 5). These data show that deacylation has no effect
on pore formation between CV-1 cells and erythrocytes
or between neighbouring CV-1 cells.
Syncytia formation
CV-1 cells were infected with standardized stocks of
SV40 recombinants that allowed equal surface expres-
sion of mutant and wt HA. When infected CV-1 cells were
exposed to low pH, the acylation mutants showed a
reduced capacity to induce syncytia as compared to wt
HA (Fig. 6). This effect was observed with each acylation
mutant, although there were differences in the extent of
fusion reduction. As expected, cell cultures expressing
uncleaved HA (mutant R339G) did not induce syncytia. To
determine the contribution of the individual attachment
sites to this effect, relative syncytia formation rates were
derived as an average from several independently per-
formed experiments (Fig. 7). Syncytia formation was only
slightly reduced when mutant C551S was compared to
TABLE 1
Expression Rate and Surface Density of H7 and
Acylation Mutants in CV-1 Cells
HA expressing cells
(% of total cells)
Mean fluorescence intensity
(% wild type)
Mock 0.13 0.0
H7 wild type 42.9 100.0
C551S 39.5 105.6
C559S 39.0 97.9
C562S 45.2 100.0
C551/559S 35.1 92.1
C551/562S 40.6 98.1
C559/562S 39.7 103.5
C551/559/562S 40.8 101.1
Note. Cells infected with SV40-HA were suspended, fixed, and incu-
bated with an HA-specific monoclonal antibody (mAb) and stained by a
FITC-labeled anti mouse-Ig serum. Rate of infected cells and mean
fluorescence intensities were determined by FACS analysis. Average
values obtained from three experiments are shown.
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FIG. 3. Membrane fusion of R18-labeled guinea pig erythrocytes and HA-expressing CV-1 cells. Erythrocytes labeled with octadecylrhodamine (R18)
were adsorbed to HA-expressing CV-1 cells, which were treated with neuraminidase before hemadsorption as described in Materials and Methods.
Hemadsorption was monitored by phase contrast microscopy (top panels). Membrane fusion of erythrocytes with CV-1 cells induced by low pH-shift
(pH 5) was analyzed by fluorescence microscopy (bottom panels). Magnification: 3250.
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wild type. With all other mutants the effect was more
distinct, although there were variations the significance
of which is not clear. These data taken together indicate
that acylation is important for syncytia formation, and that
it is mainly the fatty acids at the carboxyl-terminal end
that are responsible for this effect.
DISCUSSION
As pointed out in the Introduction, conflicting results
on the role of acylation in membrane fusion have been
obtained in several previous studies performed on dif-
ferent HA subtypes. These studies included one from our
own laboratory in which the acylation mutants of FPV HA
could not be distinguished in their fusion properties from
wild type, since fusion efficiency, in general, was low
(Veit et al., 1991). Subsequently we have observed, how-
ever, that optimal expression of the biological functions
of FPV HA is only obtained when the glycoprotein is
protected by M2 or acidotropic agents from acid dena-
turation during exocytosis (Ohuchi et al., 1994). We have
therefore re-evaluated now the fusion properties by ex-
pressing HA in the presence of ammonium chloride.
Furthermore, measures were taken to express compara-
ble amounts of mutants and wild type, since it is known
that fusion depends also on the cell surface density of
HA (Ellens et al., 1990; Clague et al., 1991; Danieli et al.,
1996). When we analyzed HA under these conditions, we
observed that the fatty acid deficient mutants were un-
changed in their ability to induce membrane fusion and
pore formation but that they had a reduced capacity to
induce syncytia. These findings support the concept that
acylation of the cytoplasmic tail of FPV HA promotes
dilation of fusion pores.
The type of amino acid used for cysteine replacement
appears not to be important for the fusion activity, since
differences have not been observed in previous studies,
when cysteine was exchanged for serine, alanine, me-
thionine, proline, or tyrosine (Steinhauer et al., 1991; Veit
et al., 1991; Naim et al., 1992; Simpson and Lamb, 1992;
Philipp et al., 1995; Jin et al., 1996). On the other hand, it
has been shown in these studies that substitution of a
given cysteine affects the efficiency of acylation at the
neighbouring attachment sites. Thus acylation of the
C-terminal cysteine at position 562 was increased when
the other attachment sites were eliminated (Naim et al.,
1992; Jin et al., 1996). Although we did not obtain clear
evidence for such an effect in the present study, our data
show that the importance of the acylation sites for pore
dilation increases with their distance from the transmem-
brane region. Thus mutants C562S and C559S form less
syncytia than mutant C551S. The same tendency was
seen with the double mutants, again supporting a dom-
inant role of the C-terminal fatty acids.
Our results appear to be at variance with other studies
which did not obtain evidence for suppression of pore
dilation after fusion of erythrocytes with cells expressing
deacylated HA. Thus Melikyan and co-workers (1997)
reported recently that pore flickering, a very early event
in the fusion process not analyzed in our study, was
reduced by deacylation of HA (subtype 3), but that kinet-
ics and extent of membrane fusion, pore formation, and
dilation of fusion pores were not affected. It should be
pointed out that this study has focused on dilation of
fusion pores between HA-expressing CV-1 cells and
erythrocytes, whereas we have used here formation of
syncytia between CV-1 cells as a measure for pore dila-
tion. We have observed that erythrocytes swell after
fusion, whereas fusing CV-1 cells did not swell, and it
has previously been shown that cell swelling promotes
pore genesis (Melikyan et al., 1995; Nu¨ssler et al., 1997).
It is therefore conceivable that, in the study of Melikyan
and co-workers (1997), swelling of erythrocytes may
have compensated the failure of deacylated HA to en-
able pore enlargement. It should also be considered that
pores must enlarge to a greater degree to form syncytia
than to pass a 40-kDa dextran molecule (Melikyan et al.,
1997). Because of these differences in experimental ap-
proach, there may not be any conflict between both
studies.
How can acylation of the cytoplasmic tail of HA
promote pore dilation? Recent structural analyses of
several viral fusion proteins provide evidence for a
common fusion mechanism (Weissenhorn et al., 1997).
HA2 (Bullough et al., 1994) and the transmembrane
subunits of the envelope glycoproteins of Moloney
murine leukemia virus (Fass et al., 1996) and HIV-1
FIG. 4. Kinetics of membrane fusion of erythrocytes with wt and
completely deacylated HA. Hemadsorption was carried out with a
mixture (1:4) of R18-labeled and unlabeled erythrocytes. Cells were
suspended in a cuvette at 37°, and dequenching of fluorescence
intensity was monitored within 2 min after acidifying the medium with
citric acid. Percentage of fluorescence dequenching (%FDQ) is shown
for HA wt (dark squares) and for mutant C551/559/562S (open squares).
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FIG. 5. Pore formation assayed by calcein transition. Guinea pig erythrocytes filled with calcein were adsorbed to HA-expressing CV-1
cells, and photographs were taken by phase contrast microscopy (top panels). Then fusion initiated by an acidic pH-shift (pH 5) was analysed
by fluorescence microscopy showing calcein in erythrocytes and calcein entered into the cytoplasm of CV-1 cells (bottom panels). Magnifi-
cation 3250.
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(Weissenhorn et al., 1997) share the interesting struc-
tural feature of a core consisting of an extended,
triple-stranded a-helical coiled coil with the amino
terminus at its tip and carboxyl-terminal helices pack-
ing in the reverse direction against the outside of the
coiled coil. The amino-terminal fusion peptides and
the carboxyl-terminal transmembrane anchors are
therefore located at the same end of the rod-shaped
FIG. 6. Multinucleated CV-1 cells expressing wt and mutant HA. Cells infected with SV40-HA were incubated with acidic medium (pH 5) at 48 h
p.i. for 5 min and then replaced by neutral culture medium at 37°. At 52 h p.i., cell cultures were fixed with ethanol, stained with Giemsa’s solution,
and analysed under the microscope (magnification: 3100).
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fusion protein. Electron microscopy and antibody la-
belling of membrane associated HA2 provide further
support for such a structure (Wharton et al., 1995). With
the membrane anchor embedded in the viral envelope
and the fusion peptide immersed into the target mem-
brane, this structure forces both membranes into close
apposition. The model also proposes that fusion pep-
tide and membrane anchor are attached by flexible
links to the central rod. These hinges would allow
rotational mobility of both hydrophobic domains in the
adjacent membranes resulting in perturbation and
mixing of lipid bilayers and eventually in fusion (Weis-
senhorn et al., 1997). Alternatively, it is conceivable
that the hydrophobic domains are attached to HA2 by
stiff linkages as proposed for the mechanical coupling
between the ectodomain and the transmembrane se-
quence (Melikyan et al., 1995) and that formation of the
rod would not only reduce the gap between both
membranes but already enforce membrane bending
and fusion. Both models imply that the fusion peptide
has a similar function in the fusion process as the
transmembrane domain. This concept is supported by
previous studies where mutations in the fusion pep-
tide, similar to deacylation analyzed here, did not
seem to affect lipid distribution but did affect fusion
pore dilation and syncytia formation (Gething et al.,
1986a; Schoch and Blumenthal, 1993). Another intrin-
sic feature of these models is an orientational shift of
the anchor peptide within the viral membrane from a
vertical to a tilted position requiring at least partial
immersion of the cytoplasmic tail into the lipid phase.
Reduction of the hydrophobicity of the cytoplasmic tail
by deacylation should unfavour its immersion and the
tilting of the transmembrane domain and, thus, inter-
fere with the fusion process, exactly as has been
observed in the present study.
There is also evidence from other studies for a role of
the cytoplasmic tail in fusion. Although replacement of
the HA tail by other tail sequences did not affect early
events of HA-mediated fusion (Schroth-Diez et al., 1998),
recent studies with tail elongation mutants of FPV HA
indicated that an increase of the cytoplasmic tail beyond
its natural size reduces syncytia formation activity similar
to deacylation, whereas removal of the cytoplasmic tail
has no effect (Ohuchi et al., 1998). Likewise, removal of
the cytoplasmic tail did not reduce the ability of H3 HA to
induce syncytia (Simpson and Lamb, 1992). All of these
observations support the concept that the cytoplasmic
tail down regulates fusion by interfering with the free
mobility of the transmembrane domain in the lipid phase
and that its size and hydrophobicity are critical for this
effect. Why the inhibitory effect of deacylation is only
recognized when syncytia formation is analyzed is not
understood. It remains to be seen whether this observa-
tion indicates a yet unidentified mechanism specifically
responsible for pore dilation or whether it is due to
another mechanism.
MATERIALS AND METHODS
Expression of wt and mutant HA
CV-1 cells cultivated in Dulbecco’s minimal essential
medium (DMEM) supplemented with 5% foetal calf se-
rum (FCS) in 6-cm-diameter petri dishes were grown to
90% confluency and then infected with recombinant
SV40-HA wt and HA acylation mutants. Recombinant
FIG. 7. Syncytia formation by wt and acylation mutants. Syncytia were determined by counting the nuclei in cell cultures infected with SV40-HA
mutants, as shown in Fig. 6. The mean syncytia formation activities of the acylation mutants were calculated relative to wt HA (100%).
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SV40-HA viruses were originally generated from the HA
gene of influenza virus A/FPV/Rostock/34 (H7N1) using
the plasmid pA11SVL3 under the control of the late SV40
promoter as described previously (Veit et al., 1991). The
resulting virus suspensions were kept in aliquots at
220° until they were used for HA expression. In all
HA-expression studies, ammonium chloride was added
to the medium of SV40-HA-infected CV-1 cell cultures at
a final concentration of 10 mM 12 h before fusion assays
were carried out to prevent premature change of HA
conformation (Ohuchi et al., 1994). HA-expressing cells
were metabolically labeled with [35S]methionine (1000
Ci/mmol, 10 mCi/ml) in DMEM without methionine and
with [3H]palmitic acid (5 Ci/mmol, 500 mCi/ml) in DMEM
at 44 h p.i. for 4 h. Cells were lysed by RIPA buffer [1%
Triton X-100, 1% desoxycholate, 0.1% sodium dodecyl
sulfate (SDS), 0.5 M NaCl, 20 mM Tris-HCl, 10 mM EDTA,
and 10 mM iodoacetamide], and HA was immunoprecipi-
tated by anti-FPV rabbit serum and separated by SDS–
PAGE (Veit et al., 1991). [3H]palmitic acid- and [35S]me-
thionine-labeled HA1,2 bands obtained by SDS–PAGE
under nonreducing conditions were quantified by the
FUJIX BAS 1000 Bio Imaging Analyser system (Raytest,
Straubenhardt, Germany) using BAS-IIIs and BAS-TR Bio-
Imaging plates, respectively.
Flow-cytometric analysis of immunostained HA-
expressing cells
For detection of HA on the cell surfaces, CV-1 cells
infected with recombinant SV40-HA were detached from
culture dishes by EDTA and trypsin treatment 48 h p.i.
and fixed with 2% paraformaldehyde for 15 min at room
temperature. Cells were washed once with 2% glycine in
PBS (phosphate buffered saline) and incubated for 1 h at
37° with a mouse monoclonal antibody (2A11-H7) recog-
nising the neutral pH form and the low pH form of
HA followed by staining with a fluorescein isothiocya-
nate (FITC)-conjugated goat anti-mouse immunoglobulin
(Garten et al., 1992). Cells were resuspended in 1 ml PBS
and subjected to analysis on a fluorescence-activated
cell scanner (FACS) (Beckton Dickinson). Data were eval-
uated with Beckton Dickinson FACScan research soft-
ware, version 2.1. Inocula of recombinant SV40-HA virus
stocks were adjusted for the infection of CV-1 cells to
yield a sufficient number of infected cells to compare
both rate of expressing cells and surface expression
levels of HA. Since syncytia formation could be quanti-
fied only when HA expressing CV-1 cells were sur-
rounded by a sufficient number of noninfected cells, cells
were infected with 1:5 of the input virus taken for FACS
analysis. The same m.o.i. was used in the other fusion
assays.
Hemadsorption assay
Prior to the assay, CV-1 cell cultures (6 cm in diameter)
expressing HA were washed with PBS and incubated at
37° for 1 h with 0.1 units Vibrio cholerae neuraminidase
(VCNA) (Behringwerke, Marburg, Germany) in 2 ml of
DMEM. After removal of VCNA by three washes with
DMEM, the HA-expressing CV-1 cell cultures were incu-
bated with a 1% suspension of freshly prepared guinea
pig erythrocytes in DMEM for 30 min at 4° (Ohuchi et al.,
1995). Unbound and unspecifically bound erythrocytes
were removed by thorough washing with PBS. To esti-
mate expression rates of HA, hemadsorption was quan-
tified photometrically at 540 nm after hemolysis.
Fusion assay with R18-labeled erythrocytes
To determine membrane fusion, fresh guinea pig
erythrocytes were labeled with the hydrophobic fluores-
cence dye octadecylrhodamine (R18) (Molecular Probes,
Eugene, OR) according to a slightly modified protocol
(Morris et al., 1989). In short, 15 ml of a 2 mM R18 stock
solution in ethanol was added to 10 ml of a 1% erythro-
cyte suspension in PBS and incubated in the dark for 20
min at 37°. Erythrocytes were washed twice with PBS
containing 5% bovine serum albumin (BSA) to remove
unbound dye. R18-labeled erythrocytes were resus-
pended in PBS and used for hemadsorption as de-
scribed above. After removal of unbound erythrocytes
from the cell culture, fusion was induced by exposure of
the cells to prewarmed RPMI medium containing 0.1%
BSA and 5 mM 2-N-[morpholino] ethanesulfonic acid
adjusted to pH 5.0 for 5 min at 37°. After changing the pH
5.0 medium against the DMEM with neutral pH and
further incubation of the cells for 5 min at 37°, the
dispersion of R18 on cells was examined under a Zeiss
Axiophot microscope equipped with UV optics and pho-
tographically recorded (magnification 3250).
Kinetics of membrane fusion
Fusion kinetics were measured by the fluorescence
dequenching (FDQ) assay using R18-labeled erythro-
cytes. To enable maximal dilution of R18 during mem-
brane fusion, R18-labeled erythrocytes were mixed
with unlabeled erythrocytes at a 1:4 ratio before hem-
adsorption. After removal of unbound erythrocytes
CV-1 cells were trypsinized. A 50-ml aliquot of the CV-1
cell-erythrocyte suspension containing about 5 3 104
CV-1 cells was added to 1.95 ml PBS, pH 7.2, at 37° in
a thermostatic cuvette and stirred. Fusion was in-
duced by addition of an appropriate amount of 0.25 M
citric acid to lower the pH to 5.0. The R18 fluorescence
was monitored at 560 and 590 nm excitation and
emission wavelength, respectively, using an Aminco-
Bowman AB2 spectrofluorimeter. Percentage of fluo-
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rescence dequenching (%FDQ) was determined as
described (Philipp et al., 1995).
Fusion assay with calcein-labeled erythrocytes
The cytoplasm of guinea pig erythrocytes was filled
with water-soluble calcein, a fluorescein derivative
which enters the cells as a hydrophobic acetoxymethyl
ester (calcein AM) (Molecular Probes). Calcein AM was
dissolved in DMSO and added to a 1% erythrocyte sus-
pension at a final concentration of 5 mM, immediately
mixed, and incubated at room temperature for 30 min.
Calcein-filled erythrocytes were washed twice and re-
suspended in PBS (Kemble et al., 1994). Hemadsorption
and cell-erythrocyte fusion were performed exactly as
described for the experiments with R18-labeled erythro-
cytes with the exception that CV-1 cells were incubated
for another 20 min at 37° after the acidic pH was shifted
back to neutral pH. Permeation of calcein from specifi-
cally bound erythrocytes to HA-expressing CV-1 cells
was monitored by fluorescence microscopy and re-
corded by photographing.
Syncytia formation
CV1 cells infected with recombinant SV40-HA were
exposed at 48 h p.i. to prewarmed RPMI medium con-
taining 0.1% BSA and 5 mM 2-N-[morpholino] ethanesul-
fonic acid adjusted to pH 5.0 for 5 min at 37°. After
substitution of the acidic medium by DMEM containing
5% FCS, cells were further incubated at 37° for 4 h. The
monolayer was then fixed with ethanol and stained with
10-fold diluted Giemsa’s solution. Nuclei were visualized
under an inverted microscope at 3100 magnification and
recorded by photographing. For quantitative analyses,
nuclei in polykaryons (.2 nuclei) were counted in five
randomly chosen fields of a cell culture. The average
values were determined from 7 to 10 independently per-
formed experiments. The values obtained from mutants
were set in relation to wild-type values.
ACKNOWLEDGMENTS
This study was supported by the Deutsche Forschungsgemeinschaft
(SFB 286 and SFB 312) and by the Fonds der Chemischen Industrie.
REFERENCES
Blumenthal, R., Sarkar, D. P., Durell, S., Howard, D. E., and Morris, S. J.
(1996). Dilation of the hemagglutinin fusion pore revealed by the
kinetics of individual cell-cell fusion events. J. Cell Biol. 135, 63–71.
Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994).
Structure of influenza hemagglutinin at the pH of membrane fusion.
Nature 371, 37–43.
Carr, C. M., and Kim, P. S. (1993). A spring-loaded mechanism for the
conformational change of influenza hemagglutinin. Cell 73, 823–832.
Clague, M. J., Schoch, C., and Blumenthal, R. (1991). Delay time for
influenza virus hemagglutinin-induced membrane fusion depends on
hemagglutinin surface density. J. Virol. 65, 2402–2407.
Danieli, T., Pelletier, S. L., Henis, Y. I., and White, J. M. (1996). Membrane
fusion mediated by influenza virus hemagglutinin requires the con-
certed action of at least three hemagglutinin trimers. J. Cell Biol. 133,
559–569.
Daniels, R. S., Downie, J. C., Hey, A. J., Knossow, M., Skehel, J. J., Wang,
M. C., and Wiley, D. C. (1985). Fusion mutants of the influenza virus
hemagglutinin glycoprotein. Cell 40, 431–439.
Ellens, H., Bentz, J., Mason, D., Zhang, F., and White, J. (1990). Fusion of
influenza hemagglutinin-expressing fibroblasts with glycophorin-
bearing liposomes: Role of hemagglutinin surface density. Biochem-
itsry 29, 9697–9707.
Fass, D., Harrison, S. C., and Kim, P. S. (1996). Retrovirus envelope
domain at 1,7 Å resolution. Nature Struct. Biol. 3, 465–469.
Garten, W., Will, C., Buckard, K., Kuroda, K., Ortmann, D., Munk, K.,
Scholtissek, C., Schnittler, H., Drenckhahn, D., and Klenk, H.-D.
(1992). Structure and assembly of hemagglutinin mutants of fowl
plague virus with impaired surface transport. J. Virol. 66, 1495–1505.
Gething, M.-J., Doms, R. W., York, D., and White, J. (1986a). Studies on
the mechanism of membrane fusion: Site-specific mutagenesis of
the hemagglutinin of influenza virus. J. Cell Biol. 102, 11–23.
Gething, M.-J., McCammon, K., and Sambrook, J. (1986b). Expression of
wild type and mutant forms of influenza hemagglutinin: The role of
folding in intracellular transport. Cell 46, 939–950.
Huang, R. T. C., Rott, R., and Klenk, H.-D. (1981). Influenza viruses cause
hemolysis and fusion of cells. Virology 110, 243–247.
Jin, H., Leser, G. P., and Lamb, R. A. (1994). The influenza virus hem-
agglutinin cytoplasmic tail is not essential for virus assembly or
infectivity. EMBO J. 13, 5504–5515.
Jin, H., Leser, G. P, Zhang, J., and Lamb, R. A. (1997). Influenza virus
hemagglutinin and neuraminidase cytoplasmic tails control particle
shape. EMBO J. 16, 1236–1247.
Jin, H., Subbarao, K., Bagai, S, Leser, G. P., Murphy, B. R., and Lamb,
R. A. (1996). Palmitylation of the influenza virus hemagglutinin (H3) is
not essential for virus assembly or infectivity. J. Virol. 70, 1406–1414.
Kanaseki, T., Kawasaki, K., Murata, M., Ikeuchi, Y., and Ohnishi, S. J.
(1997). Structural features of membrane fusion between influenza
virus and liposome as revealed by quick-freezing electron micros-
copy. J. Cell Biol. 137, 1041–1056.
Kemble, G. W., Danieli, T., and White, J. M. (1994). Lipid-anchored
influenza hemagglutinin promotes hemifusion, not complete fusion.
Cell 76, 383–391.
Klenk, H.-D., and Garten, W. (1994). Host cell proteases controlling virus
pathogenicity. Trends Microbiol. 2, 39–43.
Lamb, R. A., and Krug, R. M. (1996). Orthomyxoviridae: The viruses and
their replication. In ‘‘Fields Virology’’ (B. N. Fields, D. M. Knipe, P. M.
Howley, Eds.), 3rd ed. pp. 1353–1445. Lippincott-Raven Publishers,
Philadelphia.
Lambrecht, B., and Schmidt, M. F. G. (1986). Membrane fusion induced
by influenza virus hemagglutinin requires protein bound fatty acids.
FEBS Lett. 202, 127–132.
Melikyan, G. B., Jin, H., Lamb, R. A., and Cohen, F. S. (1997). The role of
the cytoplasmic tail region of influenza virus hemagglutinin in forma-
tion and growth of fusion pores. Virology 235, 118–128.
Melikyan, G. B., Whihte, J. M., and Cohen, F. S. (1995). GPI-anchored
influenza hemagglutinin induces hemifusion to both red blood cell
and planar bilayer membranes. J. Cell Biol. 131,, 679–691.
Morris, S. J., Sarkar, D. P., White, J. M., and Blumenthal, R. (1989).
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing
influenza hemagglutinin red blood cells. J. Biol. Chem. 264, 3972–
3978.
Naeve, C. W., and Williams, D. (1990). Fatty acids on the A/Japan/305/57
influenza virus have a role in membrane fusion. EMBO J. 9, 3957–
3866.
Naim, H. Y., Amarneh, B., Ktistakis, N. T., and Roth, M. G. (1992). Effects
293FUSION MODULATED BY ACYLATION OF INFLUENZA HA
of altering palmitoylation sites on biosynthesis and function of the
influenza virus hemagglutinin. J. Virol. 66, 7585–7588.
Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y., and Nakajima,
K. (1991). Comparison of complete amino acid sequences and re-
ceptor binding properties among 13 serotypes of hemagglutinins of
influenza A viruses. Virlolgy 182, 475–485.
Nu¨ssler, F., Clague, M., and Herrmann, A. (1997). Meta-stability of the
hemifusion intermediate induced by glycosylphosphatidylinositol-an-
chored influenza hemagglutinin. Biophys. J. 73,, 2280–2291.
Ohuchi, M., Cramer, A., Vey, M., Ohuchi, R., Garten, W., and Klenk, H.-D.
(1994). Rescue of vector-expressed fowl plague virus hemagglutinin
in biologically active form by acidotropic agents and coexpressed M2
protein. J. Virol. 68, 920–926.
Ohuchi, M., Feldmann, A., Ohuchi, R., and Klenk, H.-D. (1995). Neur-
aminidase is essential for fowl plaque virus hemagglutinin to show
hemagglutinating activity. Virology 212, 77–83.
Ohuchi, M., Fischer, C., Ohuchi, R., Herwig, A., and Klenk, H.-D. (1998).
Elongation of the cytoplasmic tail interferes with the fusion activity of
influenza virus hemagglutinin. J. Virol. 72, 3554–3559.
Philipp, H. C., Schroth, B., Veit, M., Krumbiegel, M., Herrmann, A., and
Schmidt, M. F. G. (1995). Assessment of fusogenic properties of
influenza virus hemagglutinin deacylated by site directed mutagen-
esis and hydroxylamine treatment. Virology 210, 20–28.
Schmidt, M. F. G. (1982). Acylation of viral spike glycoproteins: A feature
of enveloped RNA viruses. Virology 116, 327–338.
Schoch, C., and Blumenthal, R. (1993). Role of the fusion peptide
sequence in initial stages of influenza hemagglutinin-induced cell
fusion. J. Biol. Chem. 268, 9267–9274.
Schroth-Diez, B., Ponimaskin, E., Reverey, H., Schmidt, M. F. G., and
Herrmann, A. (1998). Fusion activity of transmembrane and cytoplas-
mic chimeras of the influenza virus glycoprotein hemagglutinin. J. Vi-
rol. 72,, 133–141.
Simpson, D. A., and Lamb, R. A. (1992). Alterations to influenza virus
hemagglutinin cytoplasmic tail modulates virus infectivity. J. Virol. 66,
790–803.
Steinhauer, D. A., Wharton, S. A., Skehel, J. J., and Wiley, D. C. (1995).
Studies of the membrane fusion activities of fusion peptide mutants
of influenza virus hemagglutinin. J. Virol. 69, 6643–6651.
Steinhauer, D. A., Wharton, S. A., Wiley, D. C., and Skehel, J. J. (1991).
Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no
effect on membrane fusion properties. Virology 184, 445–448.
Veit, M., Kretzschmar, E., Kuroda, K., Garten, W., Schmidt, M. F. G., Klenk,
H.-D., and Rott, R. (1991). Site-specific mutagenesis identifies three
cysteine residues in the cytoplasmtic tail as acylation sites of influ-
enza virus hemagglutinin. J. Virol. 65, 2491–2500.
Vey, M., Orlich, M., Adler, S., Klenk, H.-D., Rott, R., and Garten, W. (1992).
Hemagglutinin activation of pathogenic avian influenza viruses of
serotype H7 requires the protease recognition motif R-X-K/R-R. Vi-
rology 188, 408–413.
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley,
D. C. (1997). Atomic structure of the ectodomain from HIV-1 gp41.
Nature 387, 426–430.
Wharton, S. A., Cadler, L. J., Ruigrok, R. W. H., Skehel, J. J., Steinhauser,
D. A., and Wiley, D. C. (1995). Electron microscopy of antibody
complexes of influenza virus hemagglutinin in the fusion pH confor-
mation. EMBO J. 14, 240–246.
White, J. M. (1994). Fusion of influenza virus in endosomes: role of
hemagglutinin. In ‘‘Cellular Receptors for Animal Viruses’’ (E. Wim-
mer, ed.), pp. 281–301. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY.
Wiley, D. C., and Skehel, J. J. (1987). The structure and function of the
hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev.
Biochem. 56, 365–394.
Zurcher, T., Luo, G., and Palese, P. (1994). Mutations at palmitylation
sites of the influenza virus hemagglutinin affect virus formation.
J. Virol. 68, 5748–5754.
294 FISCHER ET AL.
